Feinberg Peter's Form 4 filing
Immuneering Corp (IMRX) · filed Mar 19, 2024
- Accession no.
- 0001790340-24-000028
- Filed
- Mar 19, 2024
- Trade date
- Mar 18-19, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $183.2K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Feinberg PeterCIK 0001870076 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2024 | Class A Common Stock | PPurchaseAcquired | +45,024 | $2.31 | +$104,005.44 | 56,790 | Direct | |
| Mar 18, 2024 | Class A Common Stock | PPurchaseAcquired | +4,976 | $3.05 | +$15,176.8 | 61,766 | Direct | |
| Mar 19, 2024 | Class A Common Stock | PPurchaseAcquired | +25,000 | $2.56 | +$64,000 | 86,766 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.